1. A founder EIF2AK4 mutation causes an aggressive form of pulmonary arterial hypertension in Iberian Gypsies. (7th January 2015) Authors: Tenorio, J.; Navas, P.; Barrios, E.; Fernández, L.; Nevado, J.; Quezada, C.A.; López‐Meseguer, M.; Arias, P.; Mena, R.; Lobo, J.L.; Alvarez, C.; Heath, K.; Escribano‐Subías, P.; Lapunzina, P. Journal: Clinical genetics Issue: Volume 88:Number 6(2015:Dec.) Page Start: 579 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PO-55: Effectiveness and safety of enoxaparin in the extended treatment of venous thromboembolism in active cancer patients with renal impairment: results from the RIETECAT-RI cohort study. Issue 213 (May 2022) Authors: López-Núñez, J.J.; Trujillo-Santos, J.; Bertoletti, L.; Lobo, J.L.; Visonà, A.; Otero-Candelera, R.; Ruiz-Sada, P.; De Ancos, C.; Mahé, I.; Monreal, M. Journal: Thrombosis research Issue: Issue 213(2022)Supplement 2 Page Start: S37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗